Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from JHVEPhoto

Genesco Issues Steep Guidance Cut, Blames Weak UK Market And Slower Traffic

Genesco Inc. (NYSE:GCO) stock tumbled Thursday after the company reported worse-than-expected third-quarter results.

Benzinga

Zoetis Osteoarthritis Pain Franchise Needs A Reset: Analyst

As the animal health industry navigates a rapidly evolving landscape, companies are increasingly challenged to maintain their competitive edge through innovation and strategic adaptation.

Benzinga

Why Shoe Carnival Is Moving Away From Budget Shoppers And Chasing Premium Buyers

Shoe Carnival, Inc. (NASDAQ:SCVL) reported third-quarter sales of $297.155 million on Thursday, beating the street view of $296.333 million. Comparable store sales declined 2.7%.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

This Industrial Giant Stock Hit 52-Week High On Strong Aerospace Performance

Parker Hannifin Corp. (NYSE:PH) stock is trading higher on Thursday after it reported first-quarter FY26 sales of record $5.08 billion, exceeding analyst expectations of $4.94 billion.

Benzinga

LyondellBasell Shows Resilience Despite Big Write-Downs And Weak European Market

LyondellBasell Industries (NYSE:LYB) shares surged after the company delivered stronger-than-expected third-quarter 2025 results, signaling resilience amid a challenging chemical market.

Benzinga

Why Carter's Biggest Challenge Yet Could Hit Your Kids' Closet Next

Carter’s Inc. (NYSE:CRI) on Monday reported mixed third-quarter results before the market open, with earnings coming in slightly above Wall Street estimates while revenue was marginally below expectations.

Benzinga

BNY Mellon Ready To Accelerate As Profit Margins Climb

In a rapidly evolving financial landscape, banks are seeking new avenues to boost profitability and enhance growth prospects. Bank of New York Mellon Corp (NYSE:BK) has room for margin expansion and to accelerate its growth rate, according to Keefe, Bruyette Woods.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

State Street Profit Rises As CEO Touts Record Management Fees

State Street Corporation (NYSE:STT) stock fell on Friday after reporting third-quarter results.

Benzinga

BNY Hits Record Revenue As CEO Says Growth Strategy Is Paying Off

The Bank of New York Mellon Corporation or BNY (NYSE:BK) reported third-quarter 2025 diluted EPS of $1.88 and adjusted diluted EPS of $1.91, beating the $1.77 estimate.

Benzinga

EMA Backs Amgen Drug For Rare Autoimmune Disorder

The European Medicines Agency’s (EMA) human medicines committee (CHMP) has recommended extending the therapeutic indication of Amgen Inc.’s (NASDAQ:AMGN) Uplizna (inebilizumab) to include the treatment of adult patients with active immunoglobulin G4-related disease (IgG4-RD).

Benzinga

Wolverine Expands Jordan Davis Partnership With Bold Lifestyle Collection

Wolverine, a division of Wolverine World Wide, Inc. (NYSE:WWW), announced Wednesday it is strengthening its foothold in the lifestyle market through an expanded partnership with award-winning country singer Jordan Davis.

Benzinga

Amgen Rocatinlimab's Data Shows Potential As Long-Term Therapy For Atopic Dermatitis

Amgen Inc. (NASDAQ:AMGN) and Kyowa Kirin released preliminary topline results from the ASCEND study evaluating rocatinlimab in adults and adolescents with moderate to severe atopic dermatitis (AD) on Tuesday.

Benzinga

Designer Brands, Oracle And 3 Stocks To Watch Heading Into Tuesday

With U.S. stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Benzinga

Shoe Carnival Lifts Profit Outlook As CEO Praises Rebanner Momentum, Stock Soars

Shoe Carnival, Inc. (NASDAQ:SCVL) shares surged Thursday after the company reported its second-quarter results.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Strong Aerospace Performance Fuels Parker Hannifin To Record Profit

Parker Hannifin Corp. (NYSE:PH) stock is trading higher on Thursday after it reported fiscal fourth-quarter 2025 sales of record $5.24 billion, exceeding analyst expectations of $5.10 billion.

Benzinga

Amgen Stock Sinks As Market Eyes MariTide's Next Move

Amgen Inc. (NASDAQ:AMGN) shares are trading lower on Wednesday, despite the company reporting second-quarter results that surpassed analyst expectations after markets closed on Tuesday.

Benzinga

Cencora Says Famed GLP-1 Class Products Drive Growth, Boosts Profit Outlook

Cencora, Inc. (NYSE:COR) on Wednesday reported third-quarter 2025 sales increased 8.7% to $80.66 billion, beating the consensus of $80.354 billion.

Benzinga

Zoetis Lifts Outlook As Companion Animal Portfolio Offsets Librela Decline

Animal health firm Zoetis Inc. (NYSE:ZTS) on Tuesday reported a second-quarter 2025 adjusted earnings per share of $1.76, up from $1.56 a year ago, beating the consensus of $1.61.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

LyondellBasell Defers Projects, Optimizes Portfolio To Weather Extended Cyclical Downturn

LyondellBasell Industries N.V. (NYSE:LYB) on Friday reported mixed second-quarter 2025 financial results. Its adjusted earnings missed Wall Street estimates despite revenue topping expectations.

Benzinga

Rogers Communications Lifts Outlook After Toronto Sports Deal

Canada’s Rogers Communications, Inc. (NYSE:RCI) shares edged down Wednesday, even as the company delivered an earnings beat in its second-quarter report and raised its full-year service revenue guidance.

Benzinga

Bank Of New York Mellon's Strong Q2 Profit Drives Higher 2025 Guidance

Bank of New York Mellon Corp. (NYSE:BK) on Tuesday reported better-than-expected second-quarter 2025 results, topping both revenue and earnings estimates.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

European Medicines Agency

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.